Tech Company Financing Transactions
TransEngen Funding Round
TransEngen closed a $7 million Series C investment round on 3/6/2008. Investors included Lemhi Ventures and private investors.
Transaction Overview
Company Name
Announced On
3/6/2008
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series C
Investors
Lemhi Ventures (Lead Investor) (Randy Schmidt)
Proceeds Purpose
Funds raised through this financing will allow TriHealix to build out its provider and payor solutions.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
195 Danbury Rd. Wilton Crossing Building A 280
Wilton, CT 06897
USA
Wilton, CT 06897
USA
Phone
Website
Email Address
Overview
The TransEngen is a ground breaking, intelligent transaction-based platform. The unique capabilities of the TransEngen enable us to design, develop and execute innovative and compelling solutions that are responsive to the shifting needs of the dynamic healthcare market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Randall Rogers
Chief Operating Officer
Gregory Morris
VP - Operations
Maggie O'Hara
Browse more venture capital transactions:
Prev: 3/6/2008: BlueWillow Biologics venture capital transaction
Next: 3/7/2008: Allegro Diagnostics venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs